Photoaging Clinical Trial
Official title:
Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging
Verified date | October 2020 |
Source | Integrative Skin Science and Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Recent research has reported that the maple leaf extract exhibits anti-aging effects by inhibiting elastase activity, thereby preventing the breakdown of elastin and interfering with the formation of wrinkles. Red maple leaf extract contains phenolic compounds known as glucitol-core-containing gallotannins (GCGs) which help reduce the appearance of wrinkles and may decrease skin inflammation, dark spots and pigmentation. The objective of this study is to examine the effects of topical Maplifa on the cosmetic appearance of facial lines, redness and skin tone.
Status | Completed |
Enrollment | 19 |
Est. completion date | January 15, 2020 |
Est. primary completion date | January 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 30 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Females aged 30-70 - Individuals with Fitzpatrick skin type I-IV Exclusion Criteria: - Individuals who have been on any medication that has caused a change in skin pigmentation based on the opinion of the investigator - Individuals who have history of acute or chronic disease that would likely interfere with or increase the risk on study participation at the discretion of the investigator - Individuals who have participated in any other clinical studies using the same test sites (face) and hand in the past 14 days - Individuals who are pregnant, breast feeding or planning a pregnancy within one month. (There is no concern for risk to fetus but pregnancy can alter skin pigmentation). - Female volunteers who have started a new hormonal birth control agent or had a change in their hormonal birth control agent within the past 60 days - Individuals who have had any medical or cosmetic procedure, such as laser resurfacing, or plastic surgery to the test site (face) within the last 6 months. This includes botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure - Individuals who are currently using or during the past 30 days have used a retinoid such as Retin A, or other Rx/OTC Retinyl A or currently using or during the past 14 days have used hydroquinone (skin lightening) - Individuals with a known history of hypersensitivity to any ingredients to the cosmetic agent that is being assessed - Individuals who have history of a psychological illness or condition that would interfere with their ability to understand and follow the requirements of the study at the discretion of the investigator. |
Country | Name | City | State |
---|---|---|---|
United States | Integrative Skin Science and Research | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
Integrative Skin Science and Research | Verdure Sciences |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pigmentation on SkinColorCatch | Assessment of pigmentation based on melanin measurement on SkinColorCatch (arbitrary units set by technology) | At 4 weeks (end of study) | |
Primary | Clinical grading of Hyperpigmentation | Assessment of hyperpigmentation based on clinical grading (categories 0-5) by blinded evaluator | At 4 weeks (end of study) | |
Primary | Erythema on SkinColorCatch | Assessment of erythema based on SkinColorCatch (arbitrary units set by technology) | At 4 weeks (end of study) | |
Primary | Clinical grading of Erythema | Assessment of erythema based on clinical grading (categories 0-5) by blinded evaluator | At 4 weeks (end of study) | |
Secondary | Centrofacial redness | Image-based analysis of redness [Skinmap level Degree of Intensity (%) on BTBP Clarity Research 3D System] | At 4 weeks (end of study) | |
Secondary | Appearance of wrinkles | Image-based analysis of wrinkles (Average severity - unitless on BTBP Clarity Research 3D System) | At 4 weeks (end of study) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05271136 -
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
|
N/A | |
Completed |
NCT05514782 -
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
|
N/A | |
Completed |
NCT04911374 -
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
|
N/A | |
Not yet recruiting |
NCT05004909 -
Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream
|
N/A | |
Completed |
NCT05039723 -
Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
|
Phase 4 | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Completed |
NCT05027282 -
Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment
|
N/A | |
Not yet recruiting |
NCT06096649 -
The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin
|
N/A | |
Completed |
NCT03661697 -
Combination Versus Laser Treatment Only
|
N/A | |
Completed |
NCT03948945 -
Efficacy and Safety of Profile HaloTM Mixed Fractional Laser on Treating of Facial and Neck Photoaging.
|
N/A | |
Completed |
NCT06148558 -
A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+
|
N/A | |
Enrolling by invitation |
NCT06188338 -
A 56-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Recruiting |
NCT06195605 -
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
|
N/A | |
Not yet recruiting |
NCT04869852 -
Effects of Mango Intake on Skin Health and Gut Microbiome Changes in Postmenopausal Women
|
N/A | |
Not yet recruiting |
NCT02126644 -
The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging
|
Phase 2 | |
Active, not recruiting |
NCT01372566 -
Effect of Platelet Rich Plasma on Photoaged Skin
|
Phase 1/Phase 2 | |
Unknown status |
NCT00842907 -
Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage
|
Phase 2 | |
Completed |
NCT03112863 -
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
|
Early Phase 1 | |
Recruiting |
NCT05386368 -
RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients
|
Phase 4 | |
Recruiting |
NCT05471947 -
TCA 15% Chemical Peel for Improvement in Hand Lentigines
|
Phase 4 |